BioSpace News Archive

Urgent Care Centers Market is Expected to Grow with High Probability Business Opportunity by 2027

Wilmington, Delaware, United States, Transparency Market Research Inc.: According to the report, the global urgent care centers market was valued at US$ 23.5 Bn in 2018 and is projected to expand at a considerable CAGR during the forecast period.

August 4, 2022
·
6 min read
Business

GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution

Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has selected the GenomOncology Precision Oncology Platform for the development of a novel ground-breaking CE-IVD Precision Oncology Solution.

August 4, 2022
·
3 min read
Business

PureTech Health: Notice of Half-Yearly 2022 Results

PureTech Health plc plans to announce its half-yearly results for the six months ended June 30, 2022, on Thursday, August 25, 2022.

August 4, 2022
·
3 min read
Moberg Pharma and Padagis sign agreement for MOB-015 in Israel

Moberg Pharma AB has signed a distribution agreement with Padagis Israel Agencies Ltd. for MOB-015 in Israel and the Palestinian territories.

August 4, 2022
·
2 min read
Forbion Co-leads $70 Million Financing of F2G to Advance Development and Commercialization of New Antifungal Agent Olorofim

Forbion, a leading European life sciences venture capital firm, today announces the $70 million financing of F2G Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections with a high unmet medical need.

August 4, 2022
·
5 min read
Business

Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Sol-Gel Technologies, Ltd., a dermatology company focused on identifying, developing, commercializing or partnering branded and generic topical drug products for the treatment of skin diseases, announced financial results for the second quarter ended June 30, 2022 and provided a corporate update.

August 4, 2022
·
11 min read
Business

Biodesix Announces Second Quarter 2022 Results and Highlights

Biodesix, Inc., a leading data-driven diagnostic solutions company with a focus in lung disease, announced its financial and operating results for second quarter ended June 30, 2022 and provided a corporate update.

August 4, 2022
·
9 min read
Business

Compugen Reports Second Quarter 2022 Results

Compugen Ltd., a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, provided a corporate update and announced financial results for the second quarter ended June 30, 2022.

August 4, 2022
·
11 min read
Genetown

Seres Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference

Seres Therapeutics, Inc., a leading microbiome therapeutics company, announced that Eric Shaff, President and Chief Executive Officer, will participate in a discussion at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10 at 12:30 p.m. ET.

August 4, 2022
·
1 min read
Business

Aeglea BioTherapeutics Reports Second Quarter 2022 Financial Results and Provides Program Updates

Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare metabolic diseases, today announced financial results for the second quarter ended June 30, 2022 and provided program updates.

August 4, 2022
·
11 min read